Organization
Ascension Health
3 clinical trials
2 abstracts
Clinical trial
Calcium Administration to Prevent Hypotension Caused by Diltiazem Administration in the Treatment of Atrial Fibrillation With Rapid Ventricular ResponseStatus: Not yet recruiting, Estimated PCD: 2025-01-31
Clinical trial
Prophylactic Lisinopril to Prevent Anthracycline Induced Left Ventricular Systolic Dysfunction (PLAID) Study.Status: Withdrawn, Estimated PCD: 2018-12-15
Clinical trial
Petrolatum's Effect on Initial Symptoms of Nonscalp Seborrheic Dermatitis and Preventing ExacerbationStatus: Terminated, Estimated PCD: 2012-02-01
Abstract
End-of-life spending analysis of randomized trial of machine learning nudges to prompt serious illness communication among patients with cancer.Org: Perelman School of Medicine, University of Pennsylvania, Ascension Health, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Dana-Farber Cancer Institute,
Abstract
Association of remote, longitudinal patient-reported outcomes (PROs) and step counts with hospitalization or death among patients with advanced cancer undergoing chemotherapy: Secondary analysis of the PROStep randomized trial.Org: Perelman School of Medicine, University of Pennsylvania, Hospital of the University of Pennsylvania, Penn Medicine at Lancaster General Health, Ascension Health,